التفاصيل البيبلوغرافية
| العنوان: |
Further evolution toward effective therapy for acute ischemic stroke. |
| المؤلفون: |
Fisher, Marc, Bogousslavsky, Julien, Fisher, M, Bogousslavsky, J |
| المصدر: |
JAMA: Journal of the American Medical Association; 4/22/98, Vol. 279 Issue 16, p1298-1303, 6p, 1 Diagram, 1 Chart |
| مصطلحات موضوعية: |
CEREBROVASCULAR disease, BRAIN disease treatment, THERAPEUTIC use of antioxidants, CALCIUM antagonists, GROWTH factors, STREPTOKINASE, TISSUE plasminogen activator, PLASMINOGEN activators, NEUROPROTECTIVE agents, GABA agents, ANIMALS, CEREBRAL embolism & thrombosis, CEREBRAL ischemia, CLINICAL trials, THROMBOLYTIC therapy, PATIENT selection, THERAPEUTICS |
| مستخلص: |
The effective treatment of acute ischemic stroke remains an important goal of modern medicine and substantive advances are occurring. Recently, thrombolytic therapy with tissue-type plasminogen activator was approved for selected patients with acute ischemic stroke when therapy is started within 3 hours of onset. Streptokinase therapy for acute ischemic stroke has not been shown to be effective and is associated with an increased risk of hemorrhage, although it was not evaluated as early after stroke onset as tissue-type plasminogen activator. Various types of neuroprotective interventions are effective in animal models, but none has yet been proven effective in patients. In the future, combinations of thrombolytic and neuroprotective drugs may be used to attempt maximum rates of recovery after acute ischemic stroke. For combination therapy to achieve its maximum potential, patients with acute ischemic stroke will have to be carefully selected and treated. [ABSTRACT FROM AUTHOR] |
|
Copyright of JAMA: Journal of the American Medical Association is the property of American Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
